Back to top

medical-devices: Archive

Zacks Equity Research

GEHC Unifies bkActiv With Stealth AXiS for Live Neurosurgery Imaging

GE HealthCare teams with Medtronic to integrate real-time imaging in cranial surgery, aiming to enhance precision, workflows and clinician decision-making.

MDTNegative Net Change PACBNegative Net Change PAHCNegative Net Change GEHCPositive Net Change

Zacks Equity Research

Simulations Plus Q2 Earnings & Revenues Beat, Jump Y/Y, Shares Soar

SLP beats fiscal Q2 earnings and posts solid revenue growth, but cuts full-year EPS view even as backlog rises and margins expand across software and services.

ADSKNegative Net Change SLPPositive Net Change GWRENegative Net Change BBPositive Net Change

Indrajit Bandyopadhyay

ISRG Stock Down Nearly 20% YTD: Should You Buy, Hold or Sell?

ISRG slides nearly 20% YTD despite strong procedure growth and upgrades, as valuation concerns and macro pressures weigh on near-term upside.

MDTNegative Net Change SYKNo Net Change ISRGNegative Net Change

Zacks Equity Research

NEOG Q3 Earnings & Revenues Top, Gross Margin Down, Stock Crashes

Neogen beats Q3 earnings and revenue estimates, but margins slump and stock drops nearly 3% after results.

IDXXNegative Net Change NEOGNegative Net Change GMEDNegative Net Change PAHCNegative Net Change

Moumi Mondal

AUNA Climbs 21.5% YTD, Outperforms Industry: How to Play the Stock?

AUNA S.A. rallies as Peru delivers steady growth, Mexico shows turnaround signs, and improved liquidity and cash flow boost confidence in its outlook.

THCNegative Net Change AUNANegative Net Change ARDTNegative Net Change

Zacks Equity Research

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

DVA rides on EPS growth and early IKC profitability, but flat treatment volumes and reimbursement risks raise questions about sustaining momentum.

DVANegative Net Change GMEDNegative Net Change PACBNegative Net Change BDSXNegative Net Change

Indrajit Bandyopadhyay

Can 13-15% Procedure Growth in 2026 Sustain ISRG's Premium Valuation?

Intuitive Surgical's 13-15% 2026 procedure growth signals durable demand and global expansion, but macro and policy risks could test its premium valuation.

SYKNo Net Change ISRGNegative Net Change ZBHPositive Net Change

Zacks Equity Research

Here's Why You Should Retain Clover Stock in Your Portfolio for Now

CLOV rides strong membership growth and an AI-driven care model, but rising costs and policy risks cloud the near-term outlook.

PAHCNegative Net Change INSPNegative Net Change CLOVPositive Net Change GEHCPositive Net Change

Zacks Equity Research

BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension

BDX seeks CE Mark for its Liverty TIPS Stent Graft, a next-gen device aimed at improving portal hypertension treatment and expanding its European footprint.

BDXNegative Net Change PACBNegative Net Change PAHCNegative Net Change GEHCPositive Net Change